-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Since 2011, the cumulative sales of high-end five-category blood cell analysis systems have exceeded 10,000 units, and the sales of fluorescent dye reagents have exceeded 2 billion yuan, forcing traditional monopolistic multinational companies to cut prices and withdraw from the Chinese market, reducing patient medical costs, and It has been put into application in thousands of hospitals in many countries and regions.
Created multiple series of fluorescent identification dyes for use in five-category blood analysis system
Created multiple series of fluorescent identification dyes for use in five-category blood analysis system Created multiple series of fluorescent identification dyes for use in five-category blood analysis systemBlood cell analysis is the first of the three major routine clinical tests, and more than 1 billion people in China conduct blood cell analysis every year
In recent years, as the basic equipment for clinical blood testing, the five-category blood cell analysis system has been ranked 15th in the list of core technologies that China has not yet controlled
In order to change the above situation, the research team of Professor Fan Jiangli from the School of Chemical Engineering of Dalian University of Technology has worked hard for several years and has joined forces with Shenzhen Mindray Biomedical Electronics Co.
Realize three original technology innovations, the overall technological level is internationally leading
Achieve three original technology innovations, the overall technical level of the world's leading, achieve three original technology innovations, the overall technical level of the world's leadingAccording to Fan Jiangli, this technological achievement revolves around the relationship between the molecular structure and performance of biomedical targeted dyes, and has made technological innovations in the following three aspects: First, the development of dye molecule design methods that enhance excited state electron transfer
The second is the invention of fluorescent recognition dyes targeting tumor cells
The third is to invent the near-infrared fluorescent recognition dye for living cell DNA
On March 26, 2019, this technological achievement passed the scientific and technological achievement appraisal organized by the China Petroleum and Chemical Industry Federation in Beijing
The intensity used
With the above three innovative research results as the core technology, Fan Jiangli’s research team has made breakthroughs in cell nucleic acid fluorescent staining detection technology, and achieved quantitative detection of leukocyte immature cells, reticulocytes, nucleated red blood cells and body fluid cells.
After the core technology is successfully developed, the research team and Shenzhen Mindray Bio-Medical Electronics Co.